Efficacy of fotemustine in recurrent/progressive gliomas:: A phase II study

被引：0
|
作者：
Laguzzi, E.
Rudà, R.
Trevisan, E.
Guarneri, D.
Mocellini, C.
Soffietti, R.
机构：
[1] Univ Turin, Div Neurooncol, Turin, Italy
[2] Div Neurol, Cuneo, Italy
来源：
NEURO-ONCOLOGY | 2006年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：347 / 347
页数：1
相关论文
共 50 条
  • [21] EFFICACY AND TOXICITY OF FRACTIONATED STEREOTAXIC RADIOTHERAPY IN THE TREATMENT OF RECURRENT GLIOMAS (PHASE-I-II STUDY)
    LAING, RW
    WARRINGTON, AP
    GRAHAM, J
    BRITTON, J
    HINES, F
    BRADA, M
    RADIOTHERAPY AND ONCOLOGY, 1993, 27 (01) : 22 - 29
  • [22] A CONCURRENT COMBINATION OF RADIATION THERAPY-FOTEMUSTINE FOR NEWLY DIAGNOSED MALIGNANT GLIOMAS, A PHASE II STUDY
    Beauchesne, P. D.
    Carnin, C.
    Bernier, V.
    Taillandier, L.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1125 - 1125
  • [23] Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas
    Ahluwalia, Manmeet S.
    Patton, Carol
    Stevens, Glen
    Tekautz, Tanya
    Angelov, Lilyana
    Vogelbaum, Michael A.
    Weil, Robert J.
    Chao, Sam
    Elson, Paul
    Suh, John H.
    Barnett, Gene H.
    Peereboom, David M.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 102 (02) : 317 - 321
  • [24] First-line temozolomide and second-line PCV in recurrent/progressive malignant gliomas:: A phase II study
    Soffietti, R
    Costanza, A
    Ducati, A
    Laguzzi, E
    Nobile, M
    Ricardi, U
    Rudà, R
    NEURO-ONCOLOGY, 2004, 6 (04) : 382 - 382
  • [25] Low-dose Fotemustine in elderly patients with recurrent glioblastoma: A phase II prospective study
    Bellu, L.
    Lombardi, G.
    Pambuku, A.
    Bergo, E.
    Zagonel, V.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S591 - S591
  • [26] Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas
    Manmeet S. Ahluwalia
    Carol Patton
    Glen Stevens
    Tanya Tekautz
    Lilyana Angelov
    Michael A. Vogelbaum
    Robert J. Weil
    Sam Chao
    Paul Elson
    John H. Suh
    Gene H. Barnett
    David M. Peereboom
    Journal of Neuro-Oncology, 2011, 102 : 317 - 321
  • [27] First-line temozolomide and second-line PCV in recurrent/progressive malignant gliomas:: a phase II study
    Rudà, R
    Costanza, A
    Laguzzi, E
    Mutani, R
    Nobile, M
    Soffietti, R
    JOURNAL OF NEUROLOGY, 2004, 251 : 10 - 10
  • [28] Phase II study of antiangiogenic (metronomic) chemotherapy for recurrent malignant gliomas
    Kesari, S.
    Schiff, D.
    Doherty, L.
    Gigas, D. C.
    Batchelor, T. T.
    Muzikansky, A.
    O'Neill, A.
    Drappatz, J.
    Chen-Plotkin, A.
    Ramakrishna, N.
    Weiss, S.
    Levy, B.
    Bradshaw, J.
    Black, P. M.
    Folkman, J.
    Kieran, M.
    Wen, P. Y.
    NEURO-ONCOLOGY, 2006, 8 (04) : 444 - 445
  • [29] Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults
    Kesari, Santosh
    Schiff, David
    Doherty, Lisa
    Gigas, Debra C.
    Batchelor, Tracy T.
    Muzikansky, Alona
    O'Neill, Alison
    Drappatz, Jan
    Chen-Plotkin, Alice S.
    Ramakrishna, Naren
    Weiss, Stephanie E.
    Levy, Brenda
    Bradshaw, Joanna
    Kracher, Jean
    Laforme, Andrea
    Black, Peter McL.
    Folkman, Judah
    Kieran, Mark
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2007, 9 (03) : 354 - 363
  • [30] A PHASE-II STUDY OF INTRAVENOUS CARBOPLATIN FOR THE TREATMENT OF RECURRENT GLIOMAS
    WARNICK, RE
    PRADOS, MD
    MACK, EE
    CHANDLER, KL
    DOZ, F
    RABBITT, JE
    MALEC, MK
    JOURNAL OF NEURO-ONCOLOGY, 1994, 19 (01) : 69 - 74
12345